Effect and mechanism of propofol on myocardial ischemia reperfusion injury in type 2 diabetic rats

Microvascular Research

Volumn 90, Issue , 2013, Pages 162-168

  Lin, Changfu ^a   Sui, Haijing ^a   Gu, Jie ^a   Yang, Xue ^a   Deng, Lin ^a   Li, Wenzhi ^a   Ding, Wengang ^a   Li, Dongmei ^a   Yang, Yingchun ^b  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; ENDOTHELIN 1; NITRIC OXIDE; PROPOFOL; PROTEIN BAX; PROTEIN BCL 2; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART; HEART INFARCTION; HEART MUSCLE CELL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICROSCOPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SUTURE; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ADVANCED GLYCATION END PRODUCTS; AGES; AI; AREA-AT-RISK; ARR; DESCENDING BRANCH OF THE LEFT CORONARY ARTERY; ENDOTHELIN; ET-1; I/R; INDEX OF APOPTOSIS; ISCHEMIA/REPERFUSION; LAD; NITRIC OXIDE; NO; REACTIVE OXYGEN SPECIES; ROS; STREPTOZOTOCIN; STZ;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CYTOPROTECTION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; ENDOTHELIN-1; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; NITRIC OXIDE; PROPOFOL; PROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR;

EID: 84888435038     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.08.002     Document Type: Article

References (35)

1. Alegria J.R., Miller T.D., Gibbons R.J., Yi Q.L., Yusuf S. Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy. Am. Heart J. 2007, 154:743-750.
2. Avogaro A., Albiero M., Menegazzo L., de Kreutzenberg S., Fadini G.P. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 2011, 34:285-290.
3. Balyasnikova I.V., Visintine D.J., Gunnerson H.B., Paisansathan C., Baughman V.L., Minshall R.D., Danilov S.M. Propofol attenuates lung endothelial injury induced by ischemia-reperfusion and oxidative stress. Anesth. Analg. 2005, 100:929-936.
4. Basma B., Samuel M.S., Triggle C.R., Ding H. Endothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress?. Exp. Diabetes Res. 2012, 28:1-14.
5. Calles-Escandon J., Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr. Rev. 2001, 22:36-52.
6. Ebel D., Schlack W., Comfere T., Preckel B., Thamer V. Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart. Br. J. Anaesth. 1999, 83:903-908.
7. Engelhard K., Werner C., Eberspächer E., Pape M., Blobner M., Hutzler P., Kochs E. Sevoflurane and propofol influence the expression of apoptosis-regulating proteins after cerebral ischaemia and reperfusion in rats. Eur. J. Anaesthesiol. 2004, 21:530-537.
8. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 1994, 94:1621-1628.
9. Hausenloy D.J., Yellon D.M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 2013, 123:92-100.
10. Huang A., Yang Y.M., Feher A., Bagi Z., Kaley G., Sun D. Exacerbation of endothelial dysfunction during the progression of diabetes: role of oxidative stress. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 302:674-681.
11. Jin Y.C., Kim W., Ha Y.M., Shin I.W., Sohn J.T., Kim H.J., Seo H.G., Lee J.H., Chang K.C. Propofol limits rat myocardial ischemia and reperfusion injury with an associated reduction in apoptotic cell death in vivo. Vasc. Pharmacol. 2009, 50:71-77.
12. Kalani M. The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc. Health Risk Manag. 2008, 4:1061-1068.
13. Kampoli A.M., Tousoulis D., Briasoulis A., Latsios G., Papageorgiou N., Stefanadis C. Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus. Curr. Pharm. Des. 2011, 17:4147-4158.
14. Kaneto H., Katakami N., Matsuhisa M., Matsuoka T.A. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm. 2010, 2012:453892.
15. Katsuki A., Sumida Y., Urakawa H., Gabazza E.C., Murashima S., Nakatani K., Yano Y., Adachi Y. Increased oxidative stress is associated with serum levels of triglyceride, insulin resistance, and hyperinsulinemia in Japanese metabolically obese, normal-weight men. Diabetes Care 2004, 27:631-632.
16. Kobayashi I., Kokita N., Namiki A. Propofol attenuates ischaemia-reperfusion injury in the rat heart in vivo. Eur. J. Anaesthesiol. 2008, 25:144-151.
17. Lee Y.S., Kang Y.J., Kim H.J., Park M.K., Seo H.G., Lee J.H., Yun-Choi H.S., Chang K.C. Higenamine reduces apoptotic cell death by induction of hemeoxygenase-1 in rat myocardial ischemia-reperfusion injury. Apoptosis 2006, 11:1091-1100.
18. Matheus A.S., Tannus L.R., Cobas R.A., Palma C.C., Negrato C.A., Gomes Mde B. Impact of diabetes on cardiovascular disease: an update. Int. J. Hypertens. 2013, 653789.
19. McDermott B.J., McWilliams S., Smyth K., Kelso E.J., Spiers J.P., Zhao Y., Bell D., Mirakhur R.K. Protection of cardiomyocyte function by propofol during simulated ischemia is associated with a direct action to reduce pro-oxidant activity. J. Mol. Cell. Cardiol. 2007, 42:600-608.
20. Milano G., Morel S., Bonny C., Samaja M., von Segesser L.K., Nicod P., Vassalli G. A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:1828-1835.
21. Mohseni M., Mihandoost E., Shirazi A., Sepehrizadeh Z., Bazzaz J.T., Ghazi-khansari M. Melatonin may play a role in modulation of bax and bcl-2 expression levels to protect rat peripheral blood lymphocytes from gamma irradiation-induced apoptosis. Mutat. Res. 2012, 738-739:19-27.
22. Pacher P., Szabó C. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr. Opin. Pharmacol. 2006, 6:136-141.
23. Pigozzi F., Rizzo M., Fagnani F., Parisi A., Spataro A., Casasco M., Borrione P. Endothelial (dys)function: the target of physical exercise for prevention and treatment of cardiovascular disease. J. Sports Med. Phys. Fitness 2011, 51:260-267.
24. Quireze C., Montero E.F., Leitão R.M., Juliano Y., Fagundes D.J., Poli-de-Figueiredo L.F. Ischemic preconditioning prevents apoptotic cell death and necrosis in early and intermediate phases of liver ischemia-reperfusion injury in rats. J. Invest. Surg. 2006, 19:229-236.
25. Reagan-Shaw S., Nihal M., Ahsan H., Mukhtar H., Ahmad N. Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio. Prostate 2008, 68:1624-1634.
26. Rodríguez-Pascual F., Busnadiego O., Lagares D., Lamas S. Role of endothelin in the cardiovascular system. Pharmacol. Res. 2011, 63:463-472.
27. Shao H., Li J., Zhou Y., Ge Z., Fan J., Shao Z., Zeng Y. Dose-dependent protective effect of propofol against mitochondrial dysfunction in ischaemic/reperfused rat heart: role of cardiolipin. Br. J. Pharmacol. 2008, 153:1641-1649.
28. Shi F.H., Cheng Y.S., Dai D.Z., Peng H.J., Cong X.D., Dai Y. Depressed calcium-handling proteins due to endoplasmic reticulum stress and apoptosis in the diabetic heart are attenuated by argirein. Naunyn Schmiedebergs Arch. Pharmacol. 2013, 386:521-531.
29. Song Q., An X., Li D., Sodha N.R., Boodhwani M., Tian Y., Sellke F.W., Li J. Hyperglycemia attenuates angiogenic capability of survivin in endothelial cells. Microvasc. Res. 2009, 78:257-264.
30. Sui H.J., Deng L., Yang X., Li W.Z., Lin C.F., Li D.M. Effects of propofol on myocardium ischemia and reperfusion injury in rats with type 2 diabetes. J. Clin. Anesthesiol. 2012, 28:74-76.
31. Tsao P.S., Aoki N., Lefer D.J., Johnson G., Lefer A.M. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 1990, 82:1402-1412.
32. Vender R.L. Chronic hypoxic pulmonary hypertension. Cell biology to pathophysiology. Chest 1994, 106:236-243.
33. Walters A.M., Porter G.A., Brookes P.S. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ. Res. 2012, 111:1222-1236.
34. Wang HongJie, Zhang JianXin, Li LanFang, Wu HongMin The effect of propofol pretreatment on myocardium ischemia and reperfusion injury in diabetic rats. Chin. J. Anesthesiol. 2008, 28:939-943.
35. Yin H., Miao J., Ma C., Sun G., Zhang Y. β-Casomorphin-7 cause decreasing in oxidative stress and inhibiting NF-κB-iNOS-NO signal pathway in pancreas of diabetes rats. J. Food Sci. 2012, 77:278-282.